KDventures writes down Umecrine Cognition holding by SEK 226.4 million to zero

Bitget2026/10/30 12:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

KDventures announced October 30, 2026, a 100% write-down of its Umecrine Cognition holding from SEK 226.4 million to SEK 0.
The adjustment will reduce net asset value by SEK 226.4 million, equivalent to approximately SEK 0.30 per share.
The write-down follows golexanolone’s failure to demonstrate statistically significant cognitive improvement versus placebo or a fatigue benefit in its PBC trial.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KDventures AB published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

KDventures writes down Umecrine Cognition holding by SEK 226.4 million to zero

You may also like

Crypto prices